David Shin, Sr. Analyst, Investments and Research at DRI Healthcare

David Shin

Sr. Analyst, Investments and Research at DRI Healthcare | Toronto, Ontario, Canada

Profile last verified October 2026
Investment Management Verified Profile Toronto, Ontario, Canada The University of British Columbia
Verified

Work Email

***@drihealthcare.com

Last verified November 2026

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

(416) ***-*439

Canada • Phone

Free account · No credit card · 5 profiles/month

David Shin Socials
David Shin Work Experience

Health Economist at BC Cancer in November 2026 - November 2026

Analyst at Analysis Group in November 2026 - November 2026

Data Integrity Manager, Project Management at adMare BioInnovations in November 2026 - November 2026

See more See less

Project Lead at Canadian Centre for Applied Research in Cancer Control in November 2026 - November 2026

Quality Assurance Analyst II & OHS Program Lead at Phyton Biotech LLC - Dept. of Quality Assurance in November 2026 - November 2026

Research Assistant at Vancouver General Hospital - Div. of Infectious Diseases in November 2026 - November 2026

Sr. Analyst, Investments and Research at DRI Healthcare in November 2026 - Present

Director, Investments and Research at DRI Healthcare in November 2026 - Present

David Shin Education

The University of British Columbia, Master of Science (MSc)

The University of British Columbia, Bachelor of Science (BSc Honors)

David Shin Skills
GMP Validation Biotechnology Sop GLP Microbiology HPLC Chromatography FDA Lifesciences
See more See less
Cell Culture ELISA Pharmaceutical Industry CAPA Molecular Biology Western Blotting Life Sciences Standard Operating Procedure (SOP) Good Laboratory Practice (GLP)
About David Shin’s Current Company
DRI Healthcare

DRI Capital is a pioneer and global leader in healthcare royalty investing. Founded in 1992 as Drug Royalty Corporation, DRI Capital is the oldest and the largest healthcare royalty private equity fund manager in the world. In 2013, DRI closed its third managed fund, Drug Royalty III, with current equity commitments of US $1 billion from a global pool of institutional investors. This follows the successful raise in 2010 of U.S. $926 million of capital commitments for Drug Royalty II ($701M in equity for Drug Royalty II and $225M in equity for Drug Royalty II Co-Investment Fund), and the U.S. $800M raised in 2006 for Drug Royalty I ($240M in equity and $560M in debt). In 1993, Drug Royalty Corporation was listed on the Toronto Stock Exchange and remained publicly traded until 2002 when it was purchased, taken private and converted in to a global private equity fund manager business model. As of June 30, 2013, Drug Royalty I and Drug Royalty II have collectively acquired more than 40 separate international royalty streams from inventors, universities, research institutes, biotechnology and global pharmaceutical companies located around the world, payable on 29 different leading pharmaceutical products. Headquartered in Toronto, DRI Capital is a fully-integrated team of 30 investment professionals with deep life sciences industry expertise drawn from a variety of disciplines.

Discover more about DRI Healthcare
David Shin’s Colleagues
Ben Axler

Ben Axler

Toronto, Ontario, Canada

Senior Director at DRI Healthcare | Life Sciences Investor

Consultant at EVERSANA (Formerly Promidian) | Management Consulting
(November 2026 – November 2026)

David Plow

David Plow

Toronto, Ontario, Canada

Chief of Staff, DRI Healthcare

Principal, Capital Solutions at CPP Investments | Investissements RPC
(November 2026 – November 2026)

Heather Pals

Heather Pals

Toronto, Ontario, Canada

General Counsel, Chief Compliance Officer, DRI Healthcare

Associate, Capital Markets at Shearman & Sterling LLP
(November 2026 – November 2026)

Mirabel Akbari

Mirabel Akbari

Toronto, Ontario, Canada

HR Professional at DRI Healthcare

Talent Sourcing Associate at Revera Inc.
(November 2026 – November 2026)

GC

Gurminder Chahal

Toronto, Ontario, Canada

Vice President, Human Resources at DRI Healthcare

Sr. HR Business Partner, Real Estate Secured Lending at TD
(November 2026 – November 2026)

BF

Babak Farahmand

Toronto, Ontario, Canada

EVP at DRI Healthcare

Analyst at DRI Healthcare
(November 2026 – Present)

Search similar profiles
Frequently asked questions about David Shin

What is David Shin email address?

Email David Shin at [email protected] and [email protected]. This email is the most updated David Shin's email found in 2026.

How to contact David Shin?

To contact David Shin send an email to [email protected] or [email protected].

What company does David Shin work for?

David Shin works for DRI Healthcare.

What is David Shin's role at DRI Healthcare?

David Shin is Sr. Analyst, Investments and Research

What industry does David Shin work in?

David Shin works in the Investment Management industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free